HomeMy WebLinkAbout06.25.26 Board Correspondence - FW_ Post by Peter A. McCullough, MD, MPH® on X - very dangerous - circulating in the blood years after.ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening
attachments, clicking on links, or replying..
From:Clerk of the Board
To:Mutony, Heather
Cc:Lee, Lewis
Subject:Board Correspondence - FW: Post by Peter A. McCullough, MD, MPH® on X - very dangerous - circulating in the
blood years after
Date:Friday, June 26, 2026 4:37:12 PM
Attachments:image001.png
Please see Board Correspondence -
Lewis LeeAdministrative Technician - ConfidentialButte County Administration25 County Center Drive, Suite 200 • Oroville, CA 95965T: 530.552.3326www.buttecounty.ca.gov | lelee@buttecounty.ca.gov
From: lance dreiss <lancedreiss@att.net>
Sent: Thursday, June 25, 2026 6:51 AM
To: Shared Mailbox Clerk of the Board <pcbs@countyofplumas.com>;
Assemblymember.Gallagher@assembly.ca.gov; Senator.Dahle@senate.ca.gov;
davidhollister@countyofplumas.com; sheriff@countyofplumas.com; District Attorney
<District_Attorney@buttecounty.ca.gov>; Nicolereinert@countyofplumas.com; Kitts, Melissa
<mkitts@buttecounty.ca.gov>; Soderstrom, Monica <msoderstrom@buttecounty.ca.gov>; Durfee,
Peter <PDurfee@buttecounty.ca.gov>; Ronald Owens <ronald@muzzledtruth.com>; Kimmelshue,
Tod <TKimmelshue@buttecounty.ca.gov>; Pickett, Andy <APickett@buttecounty.ca.gov>; Connelly,
Bill <BConnelly@buttecounty.ca.gov>; Teeter, Doug <DTeeter@buttecounty.ca.gov>; Beaudoin,
Jarett <JBeaudoin@buttecounty.ca.gov>; Julie Threet <julie4butte5@gmail.com>; Waugh, Melanie
<mwaugh@buttecounty.ca.gov>; Ritter, Tami <TRitter@buttecounty.ca.gov>; Teri DuBose
<Teri.DuBose@mail.house.gov>; Clerk of the Board <clerkoftheboard@buttecounty.ca.gov>;
Stephens, Brad J. <BStephens@buttecounty.ca.gov>
Subject: Post by Peter A. McCullough, MD, MPH® on X - very dangerous - circulating in the blood
years after
Public Record
Using mRNA-1273 and mRNA-1283 as Precedent, @moderna_tx Scrapped Preclinical
Testing for RSV and Influenza Vaccines
Dangerous @US_FDA precedent of mRNA entering market with no information on where
it goes in the body, how long does it last, and how or if it shuts off production of its
protein target. Preclinical oncogenicity, teratogenicity, and genotoxicity studies skipped.
Without emergencies for RSV and flu, why the shortcuts? Courtesy Mike Ryan, Country
Telegraph, Australia. @McCulloughFund
https://x.com/p_mcculloughmd/status/2070129449736048669?s=43
diana dreiss